{
    "title": "AstraZeneca is set to swallow up US pharma rival Ardea Biosciences",
    "url": "https://www.dailymail.co.uk/money/markets/article-2134121/AstraZeneca-set-swallow-US-pharma-rival-Ardea-Biosciences.html",
    "date": "2012-04-23",
    "keywords": [
        "astra",
        "astrazeneca",
        "ardea",
        "month",
        "business",
        "cent",
        "drug",
        "pressure",
        "hsg",
        "roger",
        "baird",
        "gmt",
        "april",
        "view",
        "consolidation",
        "industry",
        "time",
        "lossmaking",
        "biotech",
        "share",
        "premium",
        "stock",
        "announcement",
        "deal",
        "cancer",
        "gout",
        "treatment",
        "stage",
        "development",
        "executive",
        "david",
        "brennan",
        "pipeline",
        "number",
        "patent",
        "serquel",
        "ir",
        "amgen",
        "tieup",
        "respiratory",
        "airport",
        "infrastructure",
        "brummer",
        "beware",
        "holland",
        "week",
        "glaxosmith",
        "bid",
        "partner",
        "genome",
        "maryland",
        "firm",
        "move",
        "auction",
        "spokesman",
        "market",
        "quarter",
        "thursday",
        "meeting",
        "profit",
        "chairman",
        "leif",
        "johansson",
        "schweitzer",
        "shakeup",
        "management"
    ],
    "category": [
        "money",
        "markets"
    ]
}